Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Evidence-based herbal and nutritional treatments for anxiety in psychiatric disorders / David Camfield, Erica McIntyre, Jerome Sarris, editors.

Contributor(s): Camfield, David,, editor literario | McIntyre, Erica,, editor literario | Sarris, Jerome,, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham : Springer, 2016Description: 1 recurso en línea.ISBN: 331942307X; 9783319423074.Subject: FitoterapiaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Foreword; References; Acknowledgements; Contents; 1: The Need for€Evidence-Based Herbal and€Nutritional Anxiety Treatments in€Psychiatry; 1.1 The Experience of€Anxiety; 1.2 Limitations of€Current Treatment Approaches; 1.3 Nutritional and€Herbal Treatments for€Anxiety; 1.4 Varied Mechanisms of€Anxiolytic Actions; 1.5 Challenges for€an€Emerging Herbal and€Nutraceutical Industry; 1.6 The Scope of€This Book; References; Part I: Clinical Evidence in Support of Herbal and Nutritional Treatments for Anxiety; 2: Herbal Anxiolytics with€Sedative Actions; 2.1 Introduction.
2.2 Kava (Piper methysticum)2.2.1 Overview; 2.2.2 Mechanisms of€Action; 2.2.2.1 Constituents; 2.2.3 Evidence of€Efficacy; 2.2.3.1 Anxiety; 2.2.3.2 Mental Function; 2.3 Passionflower (Passiflora incarnata); 2.3.1 Overview; 2.3.2 Mechanisms of€Action; 2.3.2.1 In Vivo Studies; 2.3.3 Evidence of€Efficacy; 2.3.3.1 Clinical Studies; 2.4 Chamomile (Matricaria recutita); 2.4.1 Overview; 2.4.2 Mechanisms of€Action; 2.4.3 Evidence of€Efficacy; 2.4.3.1 Clinical Studies; 2.5 Galphimia (Galphimia glauca); 2.5.1 Overview; 2.5.2 Mechanisms of€Action; 2.5.3 Evidence of€Efficacy.
2.5.3.1 Preclinical2.5.3.2 Clinical; 2.6 Skullcap (Scutellaria lateriflora); 2.6.1 Overview; 2.6.2 Mechanisms of€Action; 2.7 Evidence of€Efficacy; 2.7.1 Preclinical; 2.7.2 Clinical; 2.8 Valerian (Valeriana spp.); 2.8.1 Overview; 2.8.1.1 Mechanisms of€Action; 2.8.2 Evidence of€Efficacy; 2.8.3 Preclinical; 2.8.3.1 Clinical; 2.8.4 Clinical Considerations; References; 3: Adaptogens; 3.1 Introduction; 3.2 Ashwagandha (Withania somnifera); 3.2.1 Overview; 3.2.1.1 Mechanisms of€Action; 3.2.2 Evidence of€Efficacy; 3.2.2.1 Preclinical Studies; 3.2.2.2 Clinical Studies.
3.2.2.3 Safety3.3 Roseroot (Rhodiola rosea); 3.3.1 Overview; 3.3.1.1 Mechanism of€Action; 3.3.1.2 Preclinical Studies; 3.3.1.3 Clinical Studies; 3.3.1.4 Safety; 3.4 Gotu Kola (Centella asiatica); 3.4.1 Overview; 3.4.1.1 Mechanism of€Action; 3.4.1.2 Preclinical Studies; 3.4.1.3 Clinical Studies; 3.4.1.4 Safety; 3.5 Siberian Ginseng (Eleutherococcus senticosus); 3.5.1 Mechanism of€Action; 3.5.2 Preclinical Studies; 3.5.3 Clinical Studies; 3.6 Schisandra (Schisandra chinensis); 3.6.1 Mechanism of€Action; 3.6.2 Preclinical Studies; 3.6.3 Clinical Studies; 3.6.4 Safety.
3.7 Combination Preparations3.7.1 Clinical Considerations; References; 4: Cognitive Anxiolytics; 4.1 Introduction; 4.2 Brahmi (Bacopa monnieri); 4.2.1 Overview; 4.2.2 Mechanisms of€Action; 4.2.3 Evidence of€Efficacy; 4.2.3.1 Preclinical; 4.2.3.2 Acute Clinical Studies; 4.2.3.3 Chronic Clinical Studies; 4.2.4 Conclusion; 4.3 Ginkgo (Ginkgo biloba); 4.3.1 Overview; 4.3.2 Mechanisms of€Action; 4.3.2.1 Constituents; 4.3.3 Evidence of€Efficacy; 4.3.3.1 Preclinical; 4.3.3.2 Clinical; 4.3.4 Conclusion; 4.4 Lemon Balm (Melissa officinalis); 4.4.1 Overview.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RM666.H33 E953 2016 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20022573
Total holds: 0

SpringerLink

Incluye referencias bibliográficas e índice

Foreword; References; Acknowledgements; Contents; 1: The Need for€Evidence-Based Herbal and€Nutritional Anxiety Treatments in€Psychiatry; 1.1 The Experience of€Anxiety; 1.2 Limitations of€Current Treatment Approaches; 1.3 Nutritional and€Herbal Treatments for€Anxiety; 1.4 Varied Mechanisms of€Anxiolytic Actions; 1.5 Challenges for€an€Emerging Herbal and€Nutraceutical Industry; 1.6 The Scope of€This Book; References; Part I: Clinical Evidence in Support of Herbal and Nutritional Treatments for Anxiety; 2: Herbal Anxiolytics with€Sedative Actions; 2.1 Introduction.

2.2 Kava (Piper methysticum)2.2.1 Overview; 2.2.2 Mechanisms of€Action; 2.2.2.1 Constituents; 2.2.3 Evidence of€Efficacy; 2.2.3.1 Anxiety; 2.2.3.2 Mental Function; 2.3 Passionflower (Passiflora incarnata); 2.3.1 Overview; 2.3.2 Mechanisms of€Action; 2.3.2.1 In Vivo Studies; 2.3.3 Evidence of€Efficacy; 2.3.3.1 Clinical Studies; 2.4 Chamomile (Matricaria recutita); 2.4.1 Overview; 2.4.2 Mechanisms of€Action; 2.4.3 Evidence of€Efficacy; 2.4.3.1 Clinical Studies; 2.5 Galphimia (Galphimia glauca); 2.5.1 Overview; 2.5.2 Mechanisms of€Action; 2.5.3 Evidence of€Efficacy.

2.5.3.1 Preclinical2.5.3.2 Clinical; 2.6 Skullcap (Scutellaria lateriflora); 2.6.1 Overview; 2.6.2 Mechanisms of€Action; 2.7 Evidence of€Efficacy; 2.7.1 Preclinical; 2.7.2 Clinical; 2.8 Valerian (Valeriana spp.); 2.8.1 Overview; 2.8.1.1 Mechanisms of€Action; 2.8.2 Evidence of€Efficacy; 2.8.3 Preclinical; 2.8.3.1 Clinical; 2.8.4 Clinical Considerations; References; 3: Adaptogens; 3.1 Introduction; 3.2 Ashwagandha (Withania somnifera); 3.2.1 Overview; 3.2.1.1 Mechanisms of€Action; 3.2.2 Evidence of€Efficacy; 3.2.2.1 Preclinical Studies; 3.2.2.2 Clinical Studies.

3.2.2.3 Safety3.3 Roseroot (Rhodiola rosea); 3.3.1 Overview; 3.3.1.1 Mechanism of€Action; 3.3.1.2 Preclinical Studies; 3.3.1.3 Clinical Studies; 3.3.1.4 Safety; 3.4 Gotu Kola (Centella asiatica); 3.4.1 Overview; 3.4.1.1 Mechanism of€Action; 3.4.1.2 Preclinical Studies; 3.4.1.3 Clinical Studies; 3.4.1.4 Safety; 3.5 Siberian Ginseng (Eleutherococcus senticosus); 3.5.1 Mechanism of€Action; 3.5.2 Preclinical Studies; 3.5.3 Clinical Studies; 3.6 Schisandra (Schisandra chinensis); 3.6.1 Mechanism of€Action; 3.6.2 Preclinical Studies; 3.6.3 Clinical Studies; 3.6.4 Safety.

3.7 Combination Preparations3.7.1 Clinical Considerations; References; 4: Cognitive Anxiolytics; 4.1 Introduction; 4.2 Brahmi (Bacopa monnieri); 4.2.1 Overview; 4.2.2 Mechanisms of€Action; 4.2.3 Evidence of€Efficacy; 4.2.3.1 Preclinical; 4.2.3.2 Acute Clinical Studies; 4.2.3.3 Chronic Clinical Studies; 4.2.4 Conclusion; 4.3 Ginkgo (Ginkgo biloba); 4.3.1 Overview; 4.3.2 Mechanisms of€Action; 4.3.2.1 Constituents; 4.3.3 Evidence of€Efficacy; 4.3.3.1 Preclinical; 4.3.3.2 Clinical; 4.3.4 Conclusion; 4.4 Lemon Balm (Melissa officinalis); 4.4.1 Overview.

Online resource; title from PDF title page (EBSCO, viewed December 6, 2016).

There are no comments on this title.

to post a comment.
Share